UNSW & Garvan Institute Take Precision Medicine Revolution to War Against Pancreatic Cancer in Australia
Thanks to an $3.75 million grant injection from the Cancer Institute, NSW Translational Program, researchers and clinicians from UNSW and […]
Erasmus MC Spin-off Secures Seeding Funding in Rotterdam to Develop Life-Saving T-cell Therapies for Solid Tumors
An Erasmus MC biotech venture spin-off was announced recently in Rotterdam, Netherlands. Pan Cancer T B.V., founded by Prof. Dr. […]
FDA Grants Orphan Drug Designation to BCMA-targeting Specific T Cell Activating Recombinant Protein (HPN217) for Patients with Multiple Myeloma
The U.S. Food and Drug Administration decided to open the Orphan Drug Designation (ODD) to an investigational drug for the […]
University of Copenhagen Spin-out Raises $154m Targeting Novel Immune-Modulating Anti-Cancer Therapies
IO Biotech, a Danish clinical-stage biotech venture developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology raised EUR […]
University of Louisville’s Brown Cancer Center Embraces Immuno-Oncology Developed at NCI: Some Patients See Dramatic Results
A 46 year-old man residing in the Louisville, Kentucky area was given about six months to live, according to a […]
Sanofi Spends $360m to Accelerate Cell Therapy Drugs for Oncology & Infectious Disease
French pharmaceutical giant Sanofi has made an offer to acquire Kiadis, a clinical-stage biotech company developing what they refer to […]
French Biotech Pursues T-Cell Based Vaccines Targeting COVID-19—No Possible Commercialization Until 2022
Ose Immunotherapeutics will conduct a clinical trial involving up to 400 patients for an experimental COVID-19 vaccine it hopes can […]
CHOP Cancer Researchers Turn Attention to COVID-19 & Identify Potential Vaccine Targets
Cancer researchers at Children’s Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify […]
Promising Interim Results for Investigational Combination Therapies Treating Newly Diagnosed Glioblastoma
The diagnosis of Glioblastoma, an aggressive tumor of the central nervous system, changes life as we know it. Upon the initial […]
Three Research Sites to Lead Clinical Trial of I-Mab’s of TJM2 to Counter COVID-19’s Deadly Cytokine Storm
Shanghai-based I-Mab was cleared by the U.S. Food and Drug Administration to conduct a Phase I clinical trial to assess […]
